Core Viewpoint - The announcement details the shareholding changes of Shenzhen Micu Biotechnology Co., Ltd. due to a reduction in shares by its major shareholder, BGI Group, which has completed its planned share reduction without affecting the company's control structure or governance [1][5]. Shareholder Holding Situation - Before the reduction plan, BGI Group held 34,705,162 shares, accounting for 8.51% of the total share capital of the company [1]. Reduction Plan Details - The reduction plan was disclosed on September 11, 2025, allowing BGI Group to reduce its holdings by up to 12,233,893 shares (3% of total shares) through a combination of centralized bidding and block trading [2]. - The actual reduction occurred between October 14 and November 26, 2025, with BGI Group successfully reducing its holdings by 12,233,893 shares, which is 3% of the total shares [2][4]. Impact of the Reduction - The reduction led to a decrease in the combined shareholding of BGI Group and Tianfu Qingyuan Holdings from 35,969,608 shares to 30,685,679 shares, reducing their combined ownership percentage from 8.82% to 7.52% [2][4]. - This change in shareholding does not trigger a mandatory tender offer and will not result in a change of control or significant impact on the company's governance or ongoing operations [3][5].
深圳微芯生物科技股份有限公司关于5%以上股东权益变动触及1%刻度暨减持股份结果公告